Tributyrin supplement for type 2 diabetes and heart risk
Part of Hormones & metabolism clinical trials.
This study tests whether taking tributyrin (a supplement that may support gut health) improves blood sugar control and reduces inflammation and heart risk in people with type 2 diabetes. You may benefit if you are managing your diabetes but still have a higher chance of heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 2 diabetes for at least 1 year.
- Your doctor has calculated that your 10-year risk of a heart attack or stroke is at least 7.5%.
- Your diabetes and heart medications have been the same for at least 3 months.
- You have not had a heart attack, stroke, or a procedure to open blocked blood vessels.
- You do not have a chronic stomach or intestinal condition that affects how your body absorbs nutrients.
- You are not pregnant or breastfeeding, and you have no severe liver or kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a supplement called tributyrin, which may help with metabolism and weight loss, is safe and effective for people with obesity. You might qualify if you have a BMI between 30 and 45 and are not taking diabetes medications.
This study tests if a special type of fat (butyrate) can help prevent diabetes in people who are overweight and have early signs of blood sugar problems. You would take a supplement for several weeks to see if it improves how your body handles sugar.
This trial tests a supplement called tributyrin (related to butyrate) to see if it can help prevent complications from acute pancreatitis when given early after diagnosis. It is for people having their first episode of pancreatitis, not for those with certain causes or weakened immune systems.
This Phase 2 study tests whether taking taurine affects blood sugar control, cholesterol/fats, and inflammation in people with type 2 diabetes. It may help by improving these lab markers, which are linked to long-term health risks.
This study compares different diabetes medicines to see which works best for people with type 2 diabetes who also have heart or blood vessel risks. It aims to find better treatment to protect your heart and kidneys.
This trial tests a combination of treatments to lower the risk of heart disease and kidney problems in people with type 1 diabetes who already have some complications or higher risk. If you qualify, you will receive extra care aimed at preventing heart attacks, strokes, and kidney failure.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.